TLTaisheng LiMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2017Advances in HIV and HBV co-infection research- Taisheng Li, MD, PhDView Slideset
JJJidong JiaMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2017The Efficacy of antiviral therapy on the regression of liver fibrosis in CHB- Jidong Jia, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2017HIV-HCV Coinfection- Jürgen Rockstroch, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2017HIV-HCV Coinfection- Jürgen Rockstroch, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018What is the place of the monoclonal antibodies in the clinic- Julià Blanco, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Reduced drug regimens- Andrea De Luca, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Clinical development of ABX464, drug candidate for HIV functional cure- Jean-Marc Steens, MDView Slideset
KWKirsten WhitePhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018B/F/TAF in treatment-naïve HIV-1 and HIV-1 RNA suppressed switch patients- Kirsten White, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Acute hepatitis A to E, diagnosis and management - Thomas Berg, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Evaluation of pre-treatment risk factors associated with failure in HCVinfected patients naive to direct acting antivirals: particular focus on natural resistance- Silvia BarbalisciaView Slideset
SFSlim FouratiMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Selection of fitness-associated substitutions in patients failing NS5A inhibitors based therapy : analysis of HCV full-length genome deep sequencing by means of shotgun metagenomics- Slim FouratiView Slideset
FCFrancesca Ceccherini-SilbersteinPhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Management of hepatitis C therapy failures - virological perspective- Francesca Ceccherini– Silberstein, PhDView Slideset
